HighTower Advisors’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-35,641
| Closed | -$1.46M | – | 3275 |
|
|
2022
Q4 | $1.46M | Buy |
+35,641
| New | +$1.46M | ﹤0.01% | 1451 |
|
|
2021
Q3 | – | Sell |
-16,161
| Closed | -$836K | – | 3086 |
|
|
2021
Q2 | $836K | Sell |
16,161
-33,866
| -68% | -$1.75M | ﹤0.01% | 1751 |
|
|
2021
Q1 | $2.52M | Sell |
50,027
-92
| -0.2% | -$4.63K | 0.01% | 1015 |
|
|
2020
Q4 | $2.61M | Sell |
50,119
-1,053
| -2% | -$54.8K | 0.01% | 798 |
|
|
2020
Q3 | $2.23M | Buy |
+51,172
| New | +$2.23M | 0.01% | 839 |
|
|
2018
Q4 | – | Sell |
-327,271
| Closed | -$15.9M | – | 2255 |
|
|
2018
Q3 | $15.9M | Buy |
+327,271
| New | +$15.9M | 0.11% | 195 |
|
|
2017
Q3 | – | Sell |
-5,749
| Closed | -$247K | – | 2201 |
|
|
2017
Q2 | $247K | Buy |
5,749
+1
| +0% | +$43 | ﹤0.01% | 1739 |
|
|
2017
Q1 | $240K | Buy |
5,748
+200
| +4% | +$8.35K | ﹤0.01% | 1669 |
|
|
2016
Q4 | $217K | Sell |
5,548
-200
| -3% | -$7.82K | ﹤0.01% | 1637 |
|
|
2016
Q3 | $255K | Buy |
5,748
+100
| +2% | +$4.44K | ﹤0.01% | 1528 |
|
|
2016
Q2 | $236K | Hold |
5,648
| – | – | ﹤0.01% | 1418 |
|
|
2016
Q1 | $226K | Sell |
5,648
-23,427
| -81% | -$937K | ﹤0.01% | 1685 |
|
|
2015
Q4 | $1.49M | Sell |
29,075
-1,449
| -5% | -$74.1K | 0.02% | 755 |
|
|
2015
Q3 | $1.43M | Buy |
30,524
+21
| +0.1% | +$984 | 0.02% | 730 |
|
|
2015
Q2 | $3.8M | Sell |
30,503
-5,356
| -15% | -$668K | 0.06% | 339 |
|
|
2015
Q1 | $4.43M | Buy |
35,859
+3,849
| +12% | +$475K | 0.07% | 328 |
|
|
2014
Q4 | $3.46M | Buy |
32,010
+434
| +1% | +$46.9K | 0.05% | 393 |
|
|
2014
Q3 | $3.35M | Sell |
31,576
-975
| -3% | -$103K | 0.06% | 363 |
|
|
2014
Q2 | $3.38M | Sell |
32,551
-4,620
| -12% | -$480K | 0.06% | 363 |
|
|
2014
Q1 | $3.48M | Buy |
37,171
+3,556
| +11% | +$333K | 0.07% | 334 |
|
|
2013
Q4 | $2.96M | Sell |
33,615
-6,343
| -16% | -$558K | 0.06% | 344 |
|
|
2013
Q3 | $3.08M | Buy |
39,958
+4,405
| +12% | +$339K | 0.08% | 287 |
|
|
2013
Q2 | $2.51M | Buy |
+35,553
| New | +$2.51M | 0.07% | 310 |
|